Cargando…
Perspectives for licensing vaccines in Mexico
Vaccine products represent one of the most successful public health measure to this day. This has been reflected during the current COVID-19 pandemic where more than 4.87 billion people have received at least one vaccine dose. In Latin America, Mexico occupies the second position in terms of the num...
Autores principales: | Padron-Regalado, Eriko, Medina-Rivero, Emilio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272047/ https://www.ncbi.nlm.nih.gov/pubmed/35835630 http://dx.doi.org/10.1016/j.vaccine.2022.07.003 |
Ejemplares similares
-
Regulatory Pathway for Licensing Biotherapeutics in Mexico
por: López-Morales, Carlos A., et al.
Publicado: (2018) -
Vaccines for SARS-CoV-2: Lessons from Other Coronavirus Strains
por: Padron-Regalado, Eriko
Publicado: (2020) -
Correction to: Vaccines for SARS-CoV-2: Lessons from Other Coronavirus Strains
por: Padron-Regalado, Eriko
Publicado: (2020) -
STING-pathway modulation to enhance the immunogenicity of adenoviral-vectored vaccines
por: Padron-Regalado, Eriko, et al.
Publicado: (2022) -
Targeting vaccinations for the licensed dengue vaccine: Considerations for serosurvey design
por: Imai, Natsuko, et al.
Publicado: (2018)